147 related articles for article (PubMed ID: 27908730)
1. mTOR activation is critical for betulin treatment in renal cell carcinoma cells.
Cheng W; Ji S; Zhang H; Han Z; Liu Q; Wang J; Ping H
Biochem Biophys Res Commun; 2017 Jan; 482(4):1030-1036. PubMed ID: 27908730
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptotic cell death by betulin in multidrug-resistant human renal carcinoma cells.
Yim NH; Jung YP; Kim A; Kim T; Ma JY
Oncol Rep; 2015 Aug; 34(2):1058-64. PubMed ID: 26059173
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity evaluations of betulin identified from the bark of Betula platyphylla var. japonica for cancer therapy.
So HM; Eom HJ; Lee D; Kim S; Kang KS; Lee IK; Baek KH; Park JY; Kim KH
Arch Pharm Res; 2018 Aug; 41(8):815-822. PubMed ID: 30109574
[TBL] [Abstract][Full Text] [Related]
4. Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.
Son JY; Yoon S; Tae IH; Park YJ; De U; Jeon Y; Park YJ; Rhyu IJ; Lee BM; Chung KH; Lim JE; Lee SJ; Lee HW; Kwak JH; Kim HS; Choi HY
Cancer Med; 2018 Oct; 7(10):5083-5095. PubMed ID: 30160042
[TBL] [Abstract][Full Text] [Related]
5. Synergistic roles of p53 and HIF1α in human renal cell carcinoma-cell apoptosis responding to the inhibition of mTOR and MDM2 signaling pathways.
Liu QJ; Shen HL; Lin J; Xu XH; Ji ZG; Han X; Shang DH; Yang PQ
Drug Des Devel Ther; 2016; 10():745-55. PubMed ID: 26937175
[TBL] [Abstract][Full Text] [Related]
6. HMGCR inhibition stabilizes the glycolytic enzyme PKM2 to support the growth of renal cell carcinoma.
Huang J; Zhao X; Li X; Peng J; Yang W; Mi S
PLoS Biol; 2021 Apr; 19(4):e3001197. PubMed ID: 33905408
[TBL] [Abstract][Full Text] [Related]
7. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
[TBL] [Abstract][Full Text] [Related]
8. MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.
Xiang C; Cui SP; Ke Y
J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):186-192. PubMed ID: 27072960
[TBL] [Abstract][Full Text] [Related]
9. Telmisartan-Induced Cytotoxicity via G
Tsujiya Y; Hasegawa A; Yamamori M; Okamura N
Biol Pharm Bull; 2021; 44(12):1878-1885. PubMed ID: 34853271
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma.
Dey P; Son JY; Kundu A; Kim KS; Lee Y; Yoon K; Yoon S; Lee BM; Nam KT; Kim HS
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717694
[TBL] [Abstract][Full Text] [Related]
11. Betulin inhibits mTOR and induces autophagy to promote apoptosis in human osteosarcoma cell lines.
Lin YC; Chen HY; Hsieh CP; Huang YF; Chang IL
Environ Toxicol; 2020 Aug; 35(8):879-887. PubMed ID: 32190974
[TBL] [Abstract][Full Text] [Related]
12. Silibinin induces apoptosis through inhibition of the mTOR-GLI1-BCL2 pathway in renal cell carcinoma.
Ma Z; Liu W; Zeng J; Zhou J; Guo P; Xie H; Yang Z; Zheng L; Xu S; Wang X; Chang LS; He D; Li L
Oncol Rep; 2015 Nov; 34(5):2461-8. PubMed ID: 26323996
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
Li H; Jin X; Zhang Z; Xing Y; Kong X
Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
[TBL] [Abstract][Full Text] [Related]
14. Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus.
Nakayama Y; Enomoto D; Yamamoto K; Takara K
Anticancer Res; 2023 Oct; 43(10):4349-4357. PubMed ID: 37772579
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway.
Zhang Y; Fan Y; Huang S; Wang G; Han R; Lei F; Luo A; Jing X; Zhao L; Gu S; Zhao X
Cancer Sci; 2018 Dec; 109(12):3865-3873. PubMed ID: 30259603
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mitochondrial translation effectively sensitizes renal cell carcinoma to chemotherapy.
Wang B; Ao J; Yu D; Rao T; Ruan Y; Yao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):767-773. PubMed ID: 28645610
[TBL] [Abstract][Full Text] [Related]
17. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
[TBL] [Abstract][Full Text] [Related]
18. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
Wu WS; Chien CC; Chen YC; Chiu WT
PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
[TBL] [Abstract][Full Text] [Related]
19. Dual inhibition of DNA-PKcs and mTOR by CC-115 potently inhibits human renal cell carcinoma cell growth.
Zheng B; Sun X; Chen XF; Chen Z; Zhu WL; Zhu H; Gu DH
Aging (Albany NY); 2020 Oct; 12(20):20445-20456. PubMed ID: 33109772
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting prenylation augments chemotherapy efficacy in renal cell carcinoma through dual inhibition on mitochondrial respiration and glycolysis.
Huang J; Yang X; Peng X; Huang W
Biochem Biophys Res Commun; 2017 Nov; 493(2):921-927. PubMed ID: 28943437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
